SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-23-006698
Filing Date
2023-03-03
Accepted
2023-03-03 17:10:09
Documents
4
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 262633
2 pre14a_001.jpg GRAPHIC 16367
3 proxy_001.jpg GRAPHIC 186092
4 proxy_002.jpg GRAPHIC 176773
  Complete submission text file 0001493152-23-006698.txt   786486
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36268 | Film No.: 23705604
SIC: 2835 In Vitro & In Vivo Diagnostic Substances